Kenneth Hoberman - 12 Jun 2025 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Director
Signature
/s/ Kenneth Hoberman
Issuer symbol
NVCT
Transactions as of
12 Jun 2025
Net transactions value
$0
Form type
4
Filing time
12 Jun 2025, 16:30:14 UTC
Previous filing
20 Jun 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hoberman Kenneth Director C/O NUVECTIS PHARMA, INC.,, 1 BRIDGE PLAZA, SUITE 275, FORT LEE /s/ Kenneth Hoberman 12 Jun 2025 0001573722

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Award $0 +30,000 +29% $0.000000 133,140 12 Jun 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The 30,000 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Hoberman's continued service on the Company's Board of Directors on such dates.